October 2018

This month, things get sticky in our Concentrates Issue. Those of us who have been growing with the industry are no strangers to the world of concentrates. For others, hash, dabs, rosin and other forms of extracts bring a whole new journey to cannabis. Epidiolex, the newly released CBD drug for epilepsy, is a significant turning point for the industry. Its release signifies a change in government perception that many have worked towards. Read more about Epidiolex and the compound that is giving patients hope

Subscribe to Emerald to read this edition.